Artigos de revistas sobre o tema "Ferroportine-1"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Ferroportine-1".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Troadec, Marie-Berengere, Diane McVey Ward, Eric Lo, Jerry Kaplan e Ivana De Domenico. "Induction of FPN1 transcription by MTF-1 reveals a role for ferroportin in transition metal efflux". Blood 116, n.º 22 (25 de novembro de 2010): 4657–64. http://dx.doi.org/10.1182/blood-2010-04-278614.
Texto completo da fonteNekhai, Sergei, Namita Kumari, Min Xu, Altreisha Foster, Sharmin Diaz e Victor R. Gordeuk. "Ferroportin Q248H Mutation Protects From HIV-1 Infection in Vitro". Blood 120, n.º 21 (16 de novembro de 2012): 993. http://dx.doi.org/10.1182/blood.v120.21.993.993.
Texto completo da fonteLiu, Xiao-Bing, Funmei Yang e David J. Haile. "Functional consequences of ferroportin 1 mutations". Blood Cells, Molecules, and Diseases 35, n.º 1 (julho de 2005): 33–46. http://dx.doi.org/10.1016/j.bcmd.2005.04.005.
Texto completo da fonteKumari, Namita, Seyed Mehdi Nouraie, Hatajai Lassiter, Asrar Ahmad, Kathryn Anastos, Jason Lazar, Seble Kassaye et al. "Control of HIV-1 Infection By Ferroportin Q248H Mutation". Blood 134, Supplement_1 (13 de novembro de 2019): 953. http://dx.doi.org/10.1182/blood-2019-128685.
Texto completo da fonteHarada, Nobuhiko, Masaya Kanayama, Atsushi Maruyama, Aruto Yoshida, Kyoko Tazumi, Tomonori Hosoya, Junsei Mimura et al. "Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages". Archives of Biochemistry and Biophysics 508, n.º 1 (abril de 2011): 101–9. http://dx.doi.org/10.1016/j.abb.2011.02.001.
Texto completo da fonteNekhai, Sergei, Altreisha Foster, Min Xu, Xiaomei Niu, Jamie Rotimi e Victor R. Gordeuk. "Inhibition of HIV-1 by Ferroprotin Expression." Blood 112, n.º 11 (16 de novembro de 2008): 1464. http://dx.doi.org/10.1182/blood.v112.11.1464.1464.
Texto completo da fonteAmmosova, Tatiana, Andrey Ivanov e Sergei A. Nekhai. "Ferroportin Q248H Mutation Prevents Its Ubiquitination". Blood 122, n.º 21 (15 de novembro de 2013): 2196. http://dx.doi.org/10.1182/blood.v122.21.2196.2196.
Texto completo da fonteWallace, Daniel F., Jonathan M. Harris e V. Nathan Subramaniam. "Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype". American Journal of Physiology-Cell Physiology 298, n.º 1 (janeiro de 2010): C75—C84. http://dx.doi.org/10.1152/ajpcell.00621.2008.
Texto completo da fonteTabbah, Sammy, Catalin Buhimschi, Katherine Rodewald-Millen, Christopher Pierson, Vineet Bhandari, Philip Samuels e Irina Buhimschi. "Hepcidin, an Iron Regulatory Hormone of Innate Immunity, is Differentially Expressed in Premature Fetuses with Early-Onset Neonatal Sepsis". American Journal of Perinatology 35, n.º 09 (2 de fevereiro de 2018): 865–72. http://dx.doi.org/10.1055/s-0038-1626711.
Texto completo da fonteLakhal-Littleton, Samira. "Ferroportin Mediated Control of Iron Metabolism and Disease". Blood 128, n.º 22 (2 de dezembro de 2016): SCI—21—SCI—21. http://dx.doi.org/10.1182/blood.v128.22.sci-21.sci-21.
Texto completo da fonteXu, Min, Fatah Kashanchi, Altreisha Foster, Jamie Rotimi, Willie Turner, Victor R. Gordeuk e Sergei Nekhai. "Hepcidin induces HIV-1 transcription inhibited by ferroportin". Retrovirology 7, n.º 1 (2010): 104. http://dx.doi.org/10.1186/1742-4690-7-104.
Texto completo da fonteStarzyński, Rafał R., François Canonne-Hergaux, Małgorzata Lenartowicz, Wojciech Krzeptowski, Alexandra Willemetz, Agnieszka Styś, Joanna Bierła, Piotr Pietrzak, Tomasz Dziaman e Paweł Lipiński. "Ferroportin expression in haem oxygenase 1-deficient mice". Biochemical Journal 449, n.º 1 (7 de dezembro de 2012): 69–78. http://dx.doi.org/10.1042/bj20121139.
Texto completo da fonteLIU, Weidong, Souji SHIMOMURA, Hiroyasu IMANISHI, Yuna IWAMOTO, Naoto IKEDA, Masaki SAITO, Masao OHNO et al. "Hemochromatosis with Mutation of the Ferroportin 1 (IREG1) Gene". Internal Medicine 44, n.º 4 (2005): 285–89. http://dx.doi.org/10.2169/internalmedicine.44.285.
Texto completo da fonteChung, Jayong, Joseph R. Prohaska e Marianne Wessling-Resnick. "Ferroportin-1 Is Not Upregulated in Copper-Deficient Mice". Journal of Nutrition 134, n.º 3 (1 de março de 2004): 517–21. http://dx.doi.org/10.1093/jn/134.3.517.
Texto completo da fonteIacovelli, Jared, Agnieska E. Mlodnicka, Peter Veldman, Gui-Shuang Ying, Joshua L. Dunaief e Armin Schumacher. "Brain and retinal ferroportin 1 dysregulation in polycythaemia mice". Brain Research 1289 (setembro de 2009): 85–95. http://dx.doi.org/10.1016/j.brainres.2009.06.098.
Texto completo da fonteKumari, Namita, Tatiana Ammosova e Sergei Nekhai. "Heme Oxygenase-1, Ferroportin and SAMHD1 Induction By Heme Inhibits HIV-1". Blood 126, n.º 23 (3 de dezembro de 2015): 3359. http://dx.doi.org/10.1182/blood.v126.23.3359.3359.
Texto completo da fonteNekhai, Sergei A., Namita Kumari, Denitra Breuer, Charlee Mclean, Tatiana Ammosova e Subhash Dhawan. "Induction Of Ferroportin, Erg-1, p21 and IKBα In Sickle Cell Disease May Contribute To HIV-1 Inhibition". Blood 122, n.º 21 (15 de novembro de 2013): 2250. http://dx.doi.org/10.1182/blood.v122.21.2250.2250.
Texto completo da fonteParry, Christian, Guelaguetza Vazquez-meves, Andrey Ivanov, Xionghao Lin, Namita Kumari e Sergei Nekhai. "Structure of human ferroportin (SLC40A1) inferred from mass spectrometry restraints". Journal of Immunology 202, n.º 1_Supplement (1 de maio de 2019): 187.35. http://dx.doi.org/10.4049/jimmunol.202.supp.187.35.
Texto completo da fonteTheurl, Igor, Milan Theurl, Markus Seifert, Sabine Mair, Manfred Nairz, Holger Rumpold, Heinz Zoller et al. "Autocrine formation of hepcidin induces iron retention in human monocytes". Blood 111, n.º 4 (15 de fevereiro de 2008): 2392–99. http://dx.doi.org/10.1182/blood-2007-05-090019.
Texto completo da fonteXu, Youjia, Wei Zhang, Peng Zhang, Li Xiao, Aidong Wang, Pierre Sirois e Kai Li. "Downregulation of Ferroportin 1 Expression in hFOB1.19 Osteoblasts by Hepcidin". Inflammation 35, n.º 3 (14 de janeiro de 2012): 1058–61. http://dx.doi.org/10.1007/s10753-011-9411-8.
Texto completo da fonteBorges, Marina, Marina Dal'Bó Pelegrini Campioni, Dulcinéia Martins de Albuquerque, Carolina Lanaro, Fernando F. Costa e Kleber Yotsumoto Fertrin. "Aceruloplasminemia and Paroxysmal Nocturnal Hemoglobinuria Uncover Differential Expressions of Ceruloplasmin and Ferroportin in Immune Cells". Blood 132, Supplement 1 (29 de novembro de 2018): 4895. http://dx.doi.org/10.1182/blood-2018-99-113485.
Texto completo da fonteZhang, Meng-Wan, Guang Yang, Yu-Fu Zhou, Christopher Qian, Ming-Dao Mu, Ya Ke e Zhong-Ming Qian. "Regulating ferroportin-1 and transferrin receptor-1 expression: A novel function of hydrogen sulfide". Journal of Cellular Physiology 234, n.º 4 (28 de outubro de 2018): 3158–69. http://dx.doi.org/10.1002/jcp.27431.
Texto completo da fonteAbdullah, Md, Donghee Lee, Rong Li e Jong Hyuk Kim. "Abstract 4459: Metabolic liabilities of iron-dependent ferroptosis mediated through NRF2/GPX4 axis in osteosarcoma". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 4459. http://dx.doi.org/10.1158/1538-7445.am2024-4459.
Texto completo da fontePark, Bo-Yoen, e Jayong Chung. "Effect of Copper on the Regulation of Ferroportin-1 Gene Expression". Korean Journal of Nutrition 42, n.º 5 (2009): 434. http://dx.doi.org/10.4163/kjn.2009.42.5.434.
Texto completo da fonteBeutler, Ernest, James C. Barton, Vincent J. Felitti, Terri Gelbart, Carol West, Pauline L. Lee, Jill Waalen e Chris Vulpe. "Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans". Blood Cells, Molecules, and Diseases 31, n.º 3 (novembro de 2003): 305–9. http://dx.doi.org/10.1016/s1079-9796(03)00165-7.
Texto completo da fonteMok, H. "Dysregulation of ferroportin 1 interferes with spleen organogenesis in polycythaemia mice". Development 131, n.º 19 (1 de outubro de 2004): 4871–81. http://dx.doi.org/10.1242/dev.01342.
Texto completo da fonteMcGregor, J. A., M. Shayeghi, C. D. Vulpe, G. J. Anderson, A. Pietrangelo, R. J. Simpson e A. T. Mckie. "Impaired Iron Transport Activity of Ferroportin 1 in Hereditary Iron Overload". Journal of Membrane Biology 206, n.º 1 (julho de 2005): 3–7. http://dx.doi.org/10.1007/s00232-005-0768-1.
Texto completo da fonteLin, Qing, Junsheng Feng, Xiaozhen Zhao, Geng Zhang e Wei Wang. "Expression and Function of Ferroportin 1 in O-2A Progenitor Cells". Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology 296, n.º 1 (1 de novembro de 2012): 108–16. http://dx.doi.org/10.1002/ar.22610.
Texto completo da fonteKumari, Namita, Tatiana Ammosova, Sharmin Diaz, Xionghao Lin, Xiaomei Niu, Andrey Ivanov, Marina Jerebtsova, Subhash Dhawan, Patricia Oneal e Sergei Nekhai. "Increased iron export by ferroportin induces restriction of HIV-1 infection in sickle cell disease". Blood Advances 1, n.º 3 (14 de dezembro de 2016): 170–83. http://dx.doi.org/10.1182/bloodadvances.2016000745.
Texto completo da fonteZhang, An-Sheng, Shigang Xiong, Hidekazu Tsukamoto e Caroline A. Enns. "Localization of iron metabolism–related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes". Blood 103, n.º 4 (15 de fevereiro de 2004): 1509–14. http://dx.doi.org/10.1182/blood-2003-07-2378.
Texto completo da fonteMena, Natalia P., Andrés Esparza, Victoria Tapia, Pamela Valdés e Marco T. Núñez. "Hepcidin inhibits apical iron uptake in intestinal cells". American Journal of Physiology-Gastrointestinal and Liver Physiology 294, n.º 1 (janeiro de 2008): G192—G198. http://dx.doi.org/10.1152/ajpgi.00122.2007.
Texto completo da fonteSakamoto, Shinji, Mika Kirinashizawa, Yumi Mohara e Yoshihiro Watanabe. "Generation and characterization of monoclonal antibodies against mature hepcidin and its application to neutralization and quantitative alteration assay". Bioscience, Biotechnology, and Biochemistry 85, n.º 2 (20 de janeiro de 2021): 340–50. http://dx.doi.org/10.1093/bbb/zbaa013.
Texto completo da fontePapanikolaou, George, Michalis Tzilianos, John I. Christakis, Dionisios Bogdanos, Konstantina Tsimirika, Julie MacFarlane, Y. Paul Goldberg, Nikos Sakellaropoulos, Tomas Ganz e Elizabeta Nemeth. "Hepcidin in iron overload disorders". Blood 105, n.º 10 (15 de maio de 2005): 4103–5. http://dx.doi.org/10.1182/blood-2004-12-4844.
Texto completo da fonteRepo, Marleena, Markus Hannula, Juha Taavela, Jari Hyttinen, Jorma Isola, Pauliina Hiltunen, Alina Popp, Katri Kaukinen, Kalle Kurppa e Katri Lindfors. "Iron Transporter Protein Expressions in Children with Celiac Disease". Nutrients 13, n.º 3 (27 de fevereiro de 2021): 776. http://dx.doi.org/10.3390/nu13030776.
Texto completo da fonteM. Ali, Zahra, Shatha H. Ali e Forat Y. Mohsen. "Assessment of Some Hematological parameters in Iraqi Women with Different Breast Cancer Stages". Iraqi Journal of Pharmaceutical Sciences ( P-ISSN: 1683 - 3597 , E-ISSN : 2521 - 3512) 29, n.º 2 (27 de dezembro de 2020): 99–106. http://dx.doi.org/10.31351/vol29iss2pp99-106.
Texto completo da fonteKnutson, Mitchell D., Mohammad R. Vafa, David J. Haile e Marianne Wessling-Resnick. "Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages". Blood 102, n.º 12 (1 de dezembro de 2003): 4191–97. http://dx.doi.org/10.1182/blood-2003-04-1250.
Texto completo da fonteValenti, L., M. Guido, P. Dongiovanni, L. Cremonesi, A. L. Fracanzani e S. Fargion. "Ferroportin-1 in the recurrence of hepatic iron overload after liver transplantation". Digestive and Liver Disease 41, n.º 7 (julho de 2009): e17-e20. http://dx.doi.org/10.1016/j.dld.2008.01.020.
Texto completo da fonteViprakasit, Vip, Alison T. Merryweather-Clarke, Yingyong Chinthammitr, Lisa Schimanski, Hal Drakesmith, Somdet Srichairatanakool, Chanin Limwongse, Alain Townsend e Kathryn J. H. Robson. "Molecular Diagnosis of the First Ferroportin Mutation (C326Y) in the Far East Causing a Dominant Form of Inherited Iron Overload." Blood 104, n.º 11 (16 de novembro de 2004): 3204. http://dx.doi.org/10.1182/blood.v104.11.3204.3204.
Texto completo da fonteRonzoni, Luisa, Alessandra Colancecco, Laura Sonzogni, Giovanna Graziadei e Maria Domenica Cappellini. "In Vitro Ferroportin Expression in Thalassemia Intermedia During Erythroid Differentiation". Blood 118, n.º 21 (18 de novembro de 2011): 5287. http://dx.doi.org/10.1182/blood.v118.21.5287.5287.
Texto completo da fonteChen, Y., Z. Zhang, K. Yang, J. Du, Y. Xu e S. Liu. "Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress". Oncogene 34, n.º 29 (6 de outubro de 2014): 3839–47. http://dx.doi.org/10.1038/onc.2014.310.
Texto completo da fonteUguen, Kevin, Chandran Ka, Gwenaelle Collod-Béroud, Marlène Le Tertre, Julie Guellec, Claude Férec, Christophe Béroud, Isabelle Callebaut e Gérald Le Gac. "The Spectra of Disease-Causing Mutations in the Ferroportin 1 (SLC40A1) Encoding Gene and Related Iron Overload Phenotypes (Hemochromatosis Type 4 and Ferroportin Disease)". Human Mutation 2023 (13 de junho de 2023): 1–22. http://dx.doi.org/10.1155/2023/5162256.
Texto completo da fonteJouanolle, Anne-Marie, Véronique Douabin-Gicquel, Chantal Halimi, Olivier Loréal, Patricia Fergelot, Thierry Delacour, Anne-Sophie de Lajarte-Thirouard et al. "Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload". Journal of Hepatology 39, n.º 2 (agosto de 2003): 286–89. http://dx.doi.org/10.1016/s0168-8278(03)00148-x.
Texto completo da fonteBach, V., A. Remacha, A. Altés, M. J. Barceló, M. A. Molina e M. Baiget. "Autosomal dominant hereditary hemochromatosis associated with two novel Ferroportin 1 mutations in Spain". Blood Cells, Molecules, and Diseases 36, n.º 1 (janeiro de 2006): 41–45. http://dx.doi.org/10.1016/j.bcmd.2005.09.001.
Texto completo da fonteRoetto, Antonella, Alison T. Merryweather-Clarke, Filomena Daraio, Karen Livesey, Jennifer J. Pointon, Giuliana Barbabietola, Antonio Piga, Peter H. Mackie, Kathryn J. H. Robson e Clara Camaschella. "A valine deletion of ferroportin 1: a common mutation in hemochromatosis type 4?" Blood 100, n.º 2 (15 de julho de 2002): 733–34. http://dx.doi.org/10.1182/blood-2002-03-0693.
Texto completo da fonteLuo, Qian-Qian, Yu-Fu Zhou, Mesona Yung-Jin Chen, Li Liu, Juan Ma, Meng-Wan Zhang, Fa-Li Zhang, Ya Ke e Zhong-Ming Qian. "Fasting up-regulates ferroportin 1 expression via a Ghrelin/GHSR/MAPK signaling pathway". Journal of Cellular Physiology 233, n.º 1 (23 de maio de 2017): 30–37. http://dx.doi.org/10.1002/jcp.25931.
Texto completo da fonteLi, Yan-Qin, Bin Bai, Xiao-Xiao Cao, Hong Yan e Gui-Hua Zhuang. "Ferroportin 1 and hephaestin expression in BeWo cell line with different iron treatment". Cell Biochemistry and Function 30, n.º 3 (14 de dezembro de 2011): 249–55. http://dx.doi.org/10.1002/cbf.1843.
Texto completo da fonteMatak, Pavle, Andrija Matak, Sarah Moustafa, Dipendra K. Aryal, Eric J. Benner, William Wetsel e Nancy C. Andrews. "Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice". Proceedings of the National Academy of Sciences 113, n.º 13 (29 de fevereiro de 2016): 3428–35. http://dx.doi.org/10.1073/pnas.1519473113.
Texto completo da fonteThomas, C. "Ferroportin/IREG-1/MTP-1/SLC40A1 modulates the uptake of iron at the apical membrane of enterocytes". Gut 53, n.º 1 (1 de janeiro de 2004): 44–49. http://dx.doi.org/10.1136/gut.53.1.44.
Texto completo da fonteKumari, Namita, e Sergei A. Nekhai. "Heme and Iron Chelators Inhibit HIV-1 Through The Induction Of Heme Oxygenase 1, Ferroportin and IKBα". Blood 122, n.º 21 (15 de novembro de 2013): 2198. http://dx.doi.org/10.1182/blood.v122.21.2198.2198.
Texto completo da fonteZoller, Heinz, Igor Theurl, Robert Koch, Arthur Kaser e Günter Weiss. "Mechanisms of Iron Mediated Regulation of the Duodenal Iron Transporters Divalent Metal Transporter 1 and Ferroportin 1". Blood Cells, Molecules, and Diseases 29, n.º 3 (novembro de 2002): 488–97. http://dx.doi.org/10.1006/bcmd.2002.0587.
Texto completo da fonte